SRNE News and Press, Sorrento Therapeutics Inc. From 08/26/20

Most companies don't comment on outside reports. Sorrento Therapeutics ' (NASDAQ: SRNE) President and CEO Henry Ji even says that's generally the biotech's policy. Then he went off on short sellers in an interview posted in a tweet by RagingBull yesterday afternoon. "I am giving them a fa...

Shares of Sorrento Therapeutics (NASDAQ: SRNE) were up 4.7% as of 10:33 a.m. EDT on Wednesday after rising as much as 14.9% earlier in the day. Why did the stock bounce back after plunging earlier this week ? Sorrento didn't report any news that would provide a catalyst. Instead, it appears...

August 26, 2020 Palm Beach, FL – August 26, 2020 – The worldwide response, both private and public, to finding a therapeutic and/or vaccine for the global pandemic has brought out the best in the global community. Contrary to historical comparable situations, it appe...

Tyme Technologies (NASDAQ: TYME ) +29% as oncology research reveals potential new oral therapy TYME-19 in the fight against COVID-19. More news on: Tyme Technologies, Inc., SCWorx Corp., Immunic, Inc., Stocks on the move, , Read more ...

Gainers:  Cancer Genetics (NASDAQ: CGIX ) +142% . More news on: Cancer Genetics, Inc., iBio, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...

Onconova Therapeutics (NASDAQ: ONTX )   -71%  after announcing topline results from Phase 3 INSPIRE trial. More news on: Onconova Therapeutics, Inc., Northern Dynasty Minerals Ltd., Odonate Therapeutics, Inc., Stocks on the move, , Read more ...

Following through on its letter of intent announced on July 24, Sorrento Therapeutics (NASDAQ: SRNE ) inks a formal merger agreement with SmartPharm Therapeutics. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, ...

The combination of SmartPharm’s Gene Mab™ gene-encoded in vivo expression system and Sorrento’s SARS-CoV-2 neutralizing antibodies may potentially provide longer-acting, single injection protection against COVID-19. Beyond COVID-19, the synergies between Sorrent...

Shares of  Sorrento Therapeutics (NASDAQ: SRNE) fell on Wednesday after the biopharmaceutical company fired its chief financial officer. By the close of trading, Sorrento's stock was down 9.9%. After the market close on Tuesday, Sorrento disclosed in a Securities and Exchange Commission...

After the market closed on Tuesday, Sorrento Therapeutics (NASDAQ: SRNE) disclosed in an SEC filing that it fired Executive Vice President and Chief Financial Officer Jiong Shao, effective immediately. Shares of the stock down around 11.7% at 1:29 pm on Wednesday. Najjam Asghar, formerly So...